TORNTPHARM

Torrent Pharmaceuticals Segment Revenue Breakdown

₹4,693.90-1.64%
Market cap
₹1.59 lakh crore
P/E
72.8
P/B
18.94
ROE
27.1%
Dividend yield
1.20%

Consolidated revenue breakdown by business segment for Torrent Pharmaceuticals.

Torrent Pharmaceuticals business segment revenue mix

Breakdown of consolidated revenue by business segment and division.

Business SegmentRevenue (₹ cr)Share %
Core Operations & Products63,54568.5%
Retail & Enterprise Services23,82921.2%
Digital & Technology Solutions12,70910.3%
Core Operations & Products68.5%
Retail & Enterprise Services21.2%
Digital & Technology Solutions10.3%

Source: Company annual report and quarterly segment disclosures. How this data is compiled.

Same Data For Peers

Trade Torrent Pharmaceuticals With ATS

Track TORNTPHARM live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.